TLSA - Tiziana Life Sciences PLC

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Tiziana Life Sciences PLC

55 Park Lane
London W1K 1NA
United Kingdom
44 20 7495 2379
http://www.tizianalifesciences.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees10

Key Executives

NameTitlePayExercisedYear Born
Mr. Gabriele Marco Antonio Cerrone M.B.A., MBAFounder & Exec. Chairman124.01kN/A1972
Dr. Kunwar ShailubhaiCEO, Chief Scientific Officer & Exec. Director300kN/A1958
Mr. Tiziano LazzarettiChief Financial Officer141.34kN/A1959
Dr. Fayez M. Hamzeh M.D., Ph.D.Sr. VP of Clinical Devel.N/AN/AN/A
Dr. Andrea BrancaleScientific FounderN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as non-alcoholic steatohepatitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. It also develops TZLS-501, a human anti-interleukin-6 receptor monoclonal antibody that is in pre-clinical development. The company was founded in 2013 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.

Corporate Governance

Tiziana Life Sciences PLC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.